Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases

BACKGROUND: Since the SARS-CoV-2 pandemic has started in December 2019, millions of people have been infected all over the world. Vaccination is the most efficient tool to end this pandemic, but vaccine surveillance is necessary to identify side effects. Some studies have shown that neurological com...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouattour, Nadia, Hdiji, Olfa, Sakka, Salma, Fakhfakh, Emna, Moalla, Khadija, Daoud, Sawsan, Farhat, Nouha, Damak, Mariem, Mhiri, Chokri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601771/
https://www.ncbi.nlm.nih.gov/pubmed/34796417
http://dx.doi.org/10.1007/s10072-021-05733-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601771/
https://www.ncbi.nlm.nih.gov/pubmed/34796417
http://dx.doi.org/10.1007/s10072-021-05733-x

Ejemplares similares